Y-Biologics, Inc. (KOSDAQ:338840)

Y-Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	388,559	113,678	230,299	-	-	-
Market Cap Growth	272.31%	-50.64%	-	-	-	-
Enterprise Value	365,433	102,035	230,749	-	-	-
Last Close Price	25600.00	7690.00	15600.00	-	-	-
PS Ratio	107.58	19.73	66.19	-	-	-
PB Ratio	28.21	5.79	8.86	-	-	-
P/TBV Ratio	28.98	6.27	9.94	-	-	-
EV/Sales Ratio	101.18	17.71	66.33	-	-	-
Debt / Equity Ratio	1.39	0.04	0.11	0.25	0.21	0.16
Net Debt / Equity Ratio	-1.68	-0.58	-0.69	-0.40	-0.39	-0.82
Net Debt / EBITDA Ratio	3.43	1.78	2.31	0.51	0.73	4.27
Net Debt / FCF Ratio	4.04	1.63	2.31	0.72	0.66	2.39
Asset Turnover	0.10	0.22	0.12	0.12	0.11	0.16
Quick Ratio	1.15	10.58	7.39	1.60	2.91	3.35
Current Ratio	1.16	10.73	7.48	1.70	3.20	3.78
Return on Equity (ROE)	-49.24%	-28.23%	-90.84%	-77.73%	-54.50%	-40.90%
Return on Assets (ROA)	-14.21%	-20.30%	-21.27%	-34.84%	-24.67%	-11.53%
Return on Capital Employed (ROCE)	-59.20%	-41.10%	-37.00%	-90.60%	-54.20%	-20.30%
Earnings Yield	-2.25%	-5.67%	-9.06%	-	-	-
FCF Yield	-1.47%	-6.16%	-3.39%	-	-	-
Buyback Yield / Dilution	-3.46%	-19.30%	-1.87%	-1.01%	-21.93%	-5.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.